Clinical Trial Update: HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBC

View source ↗

Summary

This trial evaluates HER2-PET imaging as a precision tool to guide treatment with a HER2-targeted antibody-drug conjugate in metastatic breast cancer expressing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Low Breast Cancer

Drugs mentioned

• HER2-ADC

Snippet

Sponsor: Renske Altena | Conditions: Breast Cancer Stage IV, HER2-low Breast Cancer | Status: RECRUITING